Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers
Tenapanor offers a new approach to managing hyperphosphatemia in dialysis patients, balancing effectiveness with pill burden and cost considerations.
Philips will spend $150M to expand manufacturing for AI-enabled tech
The investment includes expanding manufacturing and research and development at a site in Reedsville, Pennsylvania, that makes AI-enabled ultrasound systems.
AI Teammates with Tilda Research – Life Sciences Today Podcast Episode 22
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest…
Producer prices rise as high tariff costs trickle through supply chains
“It’s going to take another two to three quarters for tariffs to play through” the inflation data, Federal Reserve Bank…
Flexport ups monthly minimum fee for fulfillment customers
The charge will leap from $500 to $5,000 in 2026, but vulnerable brands shouldn’t have trouble jumping to another 3PL,…
Despite trade worries, transportation execs see a strong market
Underlying metrics continue to point in a positive direction for freight services amid trade turmoil.
PFAS Exposure Tied to Greater Weight Regain After Adolescent Bariatric Surgery
New findings highlight environmental impacts on weight management.
Drug Trials Snapshots: EMRELIS
Drug Trials Snapshots: EMRELIS
Drug Trials Snapshot: TRYPTYR
TRYPTYR is a TRPM8 thermoreceptor agonist that treats the signs and symptoms of dry eye disease (DED) in adults with…
FDA Officials Near Decision on Aficamten for Obstructive Hypertrophic Cardiomyopathy
Aficamten offers new hope for HCM patients, showing significant clinical benefits and safety in recent trials, enhancing treatment options.